ArticleInternational ophthalmology2025
Correlation of autoantibody profiles with clinical parameters in exfoliative glaucoma patients.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExfoliative glaucoma (XFG) is characterized by elevated intraocular pressure (IOP) caused by fibrous deposits obstructing aqueous humor drainage, traditionally emphasizing mechanical factors. In this study, we aim to investigate the relationships between clinical parameters and autoimmune activity in exfoliative glaucoma (XFG) patients, and identify patterns of autoantibody reactivity among patient subgroups with differing levels of overall autoimmune activity.
methodsWe analyzed serum autoantibody profiles against 92 antigens in 116 XFG patients using an xMAP suspension bead array. Spearman correlation analysis and PERMANOVA were applied to evaluate relationships between autoantibody reactivity and clinical parameters in glaucoma management. Hierarchical clustering was used to identify clusters of patients based on overall autoantibody reactivity levels, and network analysis using shortest path mapping was utilized to explore potential connections among the proteins associated with the antigens used in this study and other proteins not targeted in this study.
resultsSignificant positive correlations were found between the clinical parameter SE and autoantibodies targeting the proteins LOXL3, CYP39A1, and HYOU1. Clustering analysis revealed distinct subgroups of patients with differing overall autoantibody reactivity levels, notably showing significant negative correlations between broad autoantibody profiles and CCT exclusively within the subgroup characterized by higher autoimmune activity. Network analysis identified CTNNB1 as a prominent multi-path intermediary connecting disparate proteins, highlighting potential common regulatory pathways.
conclusionsThis study identifies novel correlations between clinical parameters and autoimmune activity in XFG, suggesting refractive changes and corneal structural characteristics may be influenced by specific immune mechanisms. These findings underscore the value of integrating immunological profiling with clinical glaucoma assessments, potentially enhancing patient stratification and identifying possible therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.